Exyte is a Germany-based firm that offers services such as construction management and engineering and planning for sectors including biopharma and semiconductors.
Exyte completes Pharmaplan integration, unifying biopharma engineering under one European organization. Strong client demand drives record order-intake in 2025.
Exyte and JGC launch 'Nixyte', a new EPC brand for high-tech industries in Southeast Asia, focusing on semiconductors, biopharma, data centers, and battery plants.
Exyte and JGC launch 'Nixyte', a new EPC brand for high-tech industries in Southeast Asia, focusing on semiconductors, biopharma, data centers, and batteries.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.